Urology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Tanaka Y et al. – Both BOO and DUA cause a decreased urinary flow rate in women. In the short–term, urethral dilatation and distigmine bromide are efficacious for female patients with BOO and those with DUA, respectively.


Today in Voiding Dys/Incontinence...keeping you current

Frequently asked questions in the evaluation and management of overactive bladder
The Journal of Family Practice, 11/02/09

TVT and TVT-O for surgical treatment of primary stress urinary incontinence: prospective randomized trial
International Urogynecology Journal, 11/17/09

Fesoterodine for the treatment of urinary incontinence and overactive bladder
Therapeutics and Clinical Risk Management, 11/04/09

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address